TrialThe Lancet. Haematology2018

R-CHOP, radioimmunotherapy, and maintenance rituximab in untreated follicular lymphoma (SWOG S0801): a single-arm, phase 2, multicentre study.

Paul M Barr et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.